DOI QR코드

DOI QR Code

Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity

  • Shim, Byoung-Shik (Laboratory Science Division, International Vaccine Institute) ;
  • Choi, Youngjoo (Laboratory Science Division, International Vaccine Institute) ;
  • Cheon, In Su (Laboratory Science Division, International Vaccine Institute) ;
  • Song, Man Ki (Laboratory Science Division, International Vaccine Institute)
  • 투고 : 2013.05.02
  • 심사 : 2013.05.18
  • 발행 : 2013.06.30

초록

The mucosal surfaces are constantly exposed to incoming pathogens which can cause infections that result in severe morbidity and/or mortality. Studies have reported that mucosal immunity is important for providing protection against these pathogens and that mucosal vaccination is effective in preventing local infections. For many years, the sublingual mucosa has been targeted to deliver immunotherapy to treat allergic hypersensitivities. However, the potential of vaccine delivery via sublingual mucosal has received little attention until recently. Recent studies exploring such potential have documented the safety and effectiveness of sublingual immunization, demonstrating the ability of sublingual immunization to induce both systemic and mucosal immune responses against a variety of antigens, including soluble proteins, inter particulate antigens, and live-attenuated viruses. This review will summarize the recent findings that address the promising potential of sublingual immunization in proving protection against various mucosal pathogens.

키워드

참고문헌

  1. Holmgren, J. and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11(4 Suppl): S45-53. https://doi.org/10.1038/nm1213
  2. Cuburu, N., M. N. Kweon, J. H. Song, C. Hervouet, C. Luci, J. B. Sun, P. Hofman, J. Holmgren, F. Anjuere, and C. Czerkinsky. 2007. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25: 8598-8610. https://doi.org/10.1016/j.vaccine.2007.09.073
  3. Cuburu, N., M. N. Kweon, C. Hervouet, H. R. Cha, Y. Y. Pang, J. Holmgren, K. Stadler, J. T. Schiller, F. Anjuere, and C. Czerkinsky. 2009. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J. Immunol. 183: 7851-7859. https://doi.org/10.4049/jimmunol.0803740
  4. Kim, S., D. H. Joo, J. B. Lee, B. S. Shim, I. S. Cheon, J. E. Jang, H. H. Song, K. H. Kim, M. K. Song, and J. Chang. 2012. Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant. PLoS One 7: e32226. https://doi.org/10.1371/journal.pone.0032226
  5. Park, H. J., B. Ferko, Y. H. Byun, J. H. Song, G. Y. Han, E. Roethl, A. Egorov, T. Muster, B. Seong, M. N. Kweon, M. Song, C. Czerkinsky, and H. H. Nguyen. 2012. Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice. PLoS One 7: e39921. https://doi.org/10.1371/journal.pone.0039921
  6. Shim, B. S., J. A. Choi, H. H. Song, S. M. Park, I. S. Cheon, J. E. Jang, S. J. Woo, C. H. Cho, M. S. Song, H. Kim, K. J. Song, J. M. Lee, S. W. Kim, D. S. Song, Y. K. Choi, J. O. Kim, H. H. Nguyen, D. W. Kim, Y. Y. Bahk, C. H. Yun, and M. K. Song. 2013. Sublingual administration of bacteria- expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus. J. Microbiol. 51: 130-135. https://doi.org/10.1007/s12275-013-2399-z
  7. Shim, B. S., Y. K. Choi, C. H. Yun, E. G. Lee, Y. S. Jeon, S. M. Park, I. S. Cheon, D. H. Joo, C. H. Cho, M. S. Song, S. U. Seo, Y. H. Byun, H. J. Park, H. Poo, B. L. Seong, J. O. Kim, H. H. Nguyen, K. Stadler, D. W. Kim, K. J. Hong, C. Czerkinsky, and M. K. Song. 2011. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PLoS One 6: e27953. https://doi.org/10.1371/journal.pone.0027953
  8. Shim, B. S., K. Stadler, H. H. Nguyen, C. H. Yun, D. W. Kim, J. Chang, C. Czerkinsky, and M. K. Song. 2012. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain. Virol. J. 9: 215. https://doi.org/10.1186/1743-422X-9-215
  9. Brandtzaeg, P. 2009. Mucosal immunity: induction, dissemination, and effector functions. Scand. J. Immunol. 70: 505-515. https://doi.org/10.1111/j.1365-3083.2009.02319.x
  10. Yuki, Y. and H. Kiyono. 2003. New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 13: 293-310. https://doi.org/10.1002/rmv.398
  11. Hervouet, C., C. Luci, N. Cuburu, M. Cremel, S. Bekri, L. Vimeux, C. Maranon, C. Czerkinsky, A. Hosmalin, and F. Anjuere. 2010. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract. Vaccine 28: 5582-5590. https://doi.org/10.1016/j.vaccine.2010.06.033
  12. Song, J. H., H. H. Nguyen, N. Cuburu, T. Horimoto, S. Y. Ko, S. H. Park, C. Czerkinsky, and M. N. Kweon. 2008. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc. Natl. Acad. Sci. U. S. A. 105: 1644-1649. https://doi.org/10.1073/pnas.0708684105
  13. Viswanathan, R. K. and W. W. Busse. 2012. Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses. Chest 141: 1303-1314. https://doi.org/10.1378/chest.11-2800
  14. Calderon, M. A., T. B. Casale, A. Togias, J. Bousquet, S. R. Durham, and P. Demoly. 2011. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J. Allergy Clin. Immunol. 127: 30-38. https://doi.org/10.1016/j.jaci.2010.08.024
  15. Kildsgaard, J., J. Brimnes, H. Jacobi, and K. Lund. 2007. Sublingual immunotherapy in sensitized mice. Ann. Allergy Asthma Immunol. 98: 366-372. https://doi.org/10.1016/S1081-1206(10)60884-8
  16. Brimnes, J., J. Kildsgaard, H. Jacobi, and K. Lund. 2007. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis. Clin. Exp. Allergy 37: 488-497. https://doi.org/10.1111/j.1365-2222.2006.02624.x
  17. Agostinis, F., L. Tellarini, G. W. Canonica, P. Falagiani, and G. Passalacqua. 2005. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Allergy 60: 133. https://doi.org/10.1111/j.1398-9995.2004.00616.x
  18. Olaguibel, J. M. and M. J. Alvarez Puebla. 2005. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J. Investig. Allergol. Clin. Immunol. 15: 9-16.
  19. Larsen, T. H., L. K. Poulsen, M. Melac, A. Combebias, C. Andre, and H. J. Malling. 2006. Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study. Allergy 61: 1173-1176. https://doi.org/10.1111/j.1398-9995.2006.01203.x
  20. Huo, Z., S. L. Bissett, R. Giemza, S. Beddows, C. Oeser, and D. J. Lewis. 2012. Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers. PLoS One 7: e33736. https://doi.org/10.1371/journal.pone.0033736

피인용 문헌

  1. Induction of Intestinal Immunity by Mucosal Vaccines As a Means of Controlling HIV Infection vol.30, pp.11, 2013, https://doi.org/10.1089/aid.2014.0233
  2. Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine vol.16, pp.2, 2013, https://doi.org/10.1208/s12248-014-9565-z
  3. Mucosal vaccines : Novel strategies and applications for the control of pathogens and tumors at mucosal sites vol.10, pp.8, 2013, https://doi.org/10.4161/hv.29269
  4. Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system vol.10, pp.12, 2013, https://doi.org/10.4161/hv.32253
  5. Sublingual Immunization of Trivalent Human Papillomavirus DNA Vaccine in Baculovirus Nanovector for Protection against Vaginal Challenge vol.10, pp.3, 2013, https://doi.org/10.1371/journal.pone.0119408
  6. A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection vol.12, pp.8, 2013, https://doi.org/10.1021/mp500646d
  7. Noninvasive vaccination against infectious diseases vol.14, pp.7, 2013, https://doi.org/10.1080/21645515.2018.1461296
  8. Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection vol.10, pp.None, 2013, https://doi.org/10.3389/fimmu.2019.00567